CLINICAL TRIALS PROFILE FOR TINIDAZOLE
✉ Email this page to a colleague
All Clinical Trials for TINIDAZOLE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00003617 ↗ | Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach | Unknown status | Lymphoma Trials Office | Phase 3 | 1995-03-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. It is not yet known whether chlorambucil is more effective than observation in treating low-grade lymphoma of the stomach. PURPOSE: Randomized phase III trial to compare the effectiveness of chlorambucil with that of no further therapy following anti-Helicobacter therapy in treating patients with low-grade lymphoma of the stomach. |
| NCT00132171 ↗ | Helicobacter Pylori Eradication With a New Sequential Treatment | Completed | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Phase 3 | 2001-01-01 | Eradication rates of Helicobacter pylori (H. pylori) with standard triple therapy are disappointing, and studies from several countries confirm this poor performance. The study aimed to assess the eradication rate of a new sequential treatment regimen compared with conventional triple therapy for the eradication of H. pylori infection. |
| NCT00132171 ↗ | Helicobacter Pylori Eradication With a New Sequential Treatment | Completed | St. Orsola Hospital | Phase 3 | 2001-01-01 | Eradication rates of Helicobacter pylori (H. pylori) with standard triple therapy are disappointing, and studies from several countries confirm this poor performance. The study aimed to assess the eradication rate of a new sequential treatment regimen compared with conventional triple therapy for the eradication of H. pylori infection. |
| NCT00229216 ↗ | Treatment of Bacterial Vaginosis With Oral Tinidazole | Completed | Mission Pharmacal | Phase 3 | 2005-01-01 | The purpose of this study is to confirm the safety and efficacy of oral tinidazole for the treatment of bacterial vaginosis. |
| NCT00313131 ↗ | Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments | Completed | Canadian International Development Agency | Phase 3 | 2004-01-01 | This randomised controlled trial aimed to verify whether directly observed single dose treatment (with tinidazole+fluconazole) would be as effective as the longer standard treatments (metronidazole for 7 days, plus vaginal clotrimazole for 3 days) in the syndromic management of women presenting with vaginal discharge in primary health care centers of Ghana, Togo, Guinea and Mali. It was designed as an effectiveness trial, i.e. it was done under conditions typical of routine work in these health centers |
| NCT00313131 ↗ | Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments | Completed | Université de Sherbrooke | Phase 3 | 2004-01-01 | This randomised controlled trial aimed to verify whether directly observed single dose treatment (with tinidazole+fluconazole) would be as effective as the longer standard treatments (metronidazole for 7 days, plus vaginal clotrimazole for 3 days) in the syndromic management of women presenting with vaginal discharge in primary health care centers of Ghana, Togo, Guinea and Mali. It was designed as an effectiveness trial, i.e. it was done under conditions typical of routine work in these health centers |
| NCT00322465 ↗ | NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole) | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 | 2006-11-01 | This study will look at the safety, effectiveness, and tolerability of combination medications for the initial treatment of non-gonococcal urethritis (NGU). NGU is inflammation of the tube that carries urine from the bladder. NGU is caused by bacteria that may be passed from person to person during sex. This study will compare the 2 currently recommended NGU treatments, doxycycline and azithromycin, taken with tinidazole (another medication to treat certain sexually transmitted infections). Tinidazole used with doxycycline or azithromycin may cure NGU better than when doxycycline or azithromycin is used alone. Study participants will be 300 men ages 16-45 years with NGU attending sexually transmitted disease clinics in Birmingham, AL; New Orleans, LA; Durham, NC; and Baltimore, MD. Study participation will last 7 weeks and involve 3 visits. At each visit, participants will provide a urine sample, have 2 urethral swabs, and have their urethra checked for discharge indicating infection. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TINIDAZOLE
Condition Name
Clinical Trial Locations for TINIDAZOLE
Trials by Country
Clinical Trial Progress for TINIDAZOLE
Clinical Trial Phase
Clinical Trial Sponsors for TINIDAZOLE
Sponsor Name
